Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade.
Jie MeiYun CaiRui XuQing LiJiahui ChuZhiwen LuoYaying SunYuxin ShiJunying XuDi LiShuai LiangYing JiangJiayu LiuZhiwen QianJiaofeng ZhouMengyun WanYunlong YangYichao ZhuYan ZhangYongmei YinPublished in: Cancer communications (London, England) (2024)
This study introduces histopathology-based universal immuno-collagenic subtypes capable of predicting ICB responses across diverse cancer types. These findings offer insights that could contribute to tailoring personalized immunotherapeutic strategies for patients with cancer.